Historical review from 2026-11-15. Current price and availability are unconfirmed; check the original marketplace.

← Back to 2026-11-15 Deals
#18

Stacker: Peptide Tracker

Health & FitnessListed on TrustMRR· Nov 2
$15.0K
Asking Price
$456/mo
Monthly Revenue
$447/mo
Monthly Profit
2.8x
Profit Multiple
N/A
Business Age
✨

Why We Picked This

Stacker is a verified iPhone app in the growing peptide/biohacking niche generating $447/mo in profit on $456/mo revenue — an extraordinary 98% margin that reflects minimal operating costs. The $15,000 asking price works out to a 2.8x annual profit multiple, which is reasonable for a niche mobile app. However, revenue at ~$456/mo is modest in absolute terms, and the business age is not disclosed, leaving the durability of the customer base an open question. Platform verification adds meaningful credibility to the financials.

👍

Strengths

  • ✓Verified financials on TrustMRR with a data quality score of 100
  • ✓Near-perfect 98% profit margin ($447 profit on $456 revenue) indicating negligible operating costs
  • ✓Reasonable 2.8x annual profit multiple ($15K ask vs $5,364 annualized profit)
  • ✓Clear, focused use case — peptide stack logging, dosing reminders, and progress tracking on iOS
  • ✓Health and fitness niche with strong user intent and willingness to pay for specialized tools
🔎

Details to confirm

  • •Business age is not disclosed — confirm launch date and revenue history to assess trajectory and durability
  • •Request monthly revenue breakdown over at least 6–12 months to evaluate whether income is stable, growing, or declining
  • •Confirm active user count, retention rate, and churn to understand subscriber stickiness beyond the top-line profit figure
  • •Clarify App Store ranking, download volume, and primary acquisition channel to assess organic vs. paid growth dependence

Additional details to confirm

Evidence 60/100
Business age unavailableUnusually high reported profit margin

Buy vs Build: BUY

52
AI-native cash cost
$2.0K–$6.0K
Estimated time
6 weeks
Asking price
$15.0K

The core software — a mobile dose tracker with reminders and progress logging — is reproducible by a capable solo founder using AI-assisted development tools, SwiftUI or React Native, and a managed backend for roughly $2K–$6K in out-of-pocket costs over 6 weeks. However, the buy case rests on the verified recurring revenue stream and any existing App Store reviews, search ranking, and user base that would take additional time to rebuild. The verdict leans buy given the low multiple and verified profit, but the missing user-count and retention data temper confidence — a buyer should request those figures before closing.

Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.

📊

Financial Snapshot

$5K
Annual Revenue
$5K
Annual Profit
$0.5K
Monthly Revenue
34 mo
Est. Payback
Profit Margin98%
📋

Business Overview

Helps users build personalized peptide stacks, log doses, get reminders, and track protocol progress and results in one iPhone app.

📌

Quick Facts

🏢
Type
Health & Fitness
🏪
Source
TrustMRR
📌
Listed
Nov 2, 2026

Deal Score

68
Worth a Look
Evidence confidence60/100
2.8x
Good Multiple
Asking$15.0K
MRR$456/mo
Profit$447/mo
Profit Multiple2.8x
View on TrustMRR →

Opens the original listing on TrustMRR

Share this review

Know a buyer or the founder? Send them the full analysis.

Share on X
New listings by email

See tomorrow’s businesses for sale.

Get new listings with asking prices, monthly profit, deal scores, and key risks.

The best reviewed deals, concise and evidence-first. Unsubscribe anytime.

Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.